The Second Affiliated Hospital of Chongqing Medical University
🇨🇳China
The Effects of Non Harmonic and White Noise on Human Pain Sensitivity: a Study of Healthy Volunteers
Not Applicable
Completed
- Conditions
- Pain
- Interventions
- Behavioral: noise stimulation
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2024-03-13
- Target Recruit Count
- 30
- Registration Number
- NCT06165757
- Locations
- 🇨🇳
Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, Chongqing, China
Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy
Not Applicable
Completed
- Conditions
- Liver CancerHepatolithiasisHepatectomyHepatic Hemangioma
- Interventions
- Device: Remote Ischemic Conditioning Twice DailyDevice: Remote Ischemic Conditioning Once DailyDevice: Sham-Remote Ischemic Conditioning
- First Posted Date
- 2023-11-14
- Last Posted Date
- 2024-08-19
- Target Recruit Count
- 135
- Registration Number
- NCT06130436
- Locations
- 🇨🇳
The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
The Safety and Tolerability of A8G6 COVID-19 Neutralization Antibody Combined With Nasal Spray
Not Applicable
Recruiting
- Conditions
- PreventionSARS-CoV-2
- Interventions
- Biological: A8G6 SARS-CoV-2 Neutralization Antibody combination nasal sprayOther: A8G6 SARS-CoV-2 Neutralization Antibody nasal excipient
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2023-11-13
- Target Recruit Count
- 108
- Registration Number
- NCT06127498
- Locations
- 🇨🇳
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
Active, not recruiting
- Conditions
- Autoimmune Liver Disease, COVID-19
- Interventions
- Other: Different types of disease
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2023-10-25
- Target Recruit Count
- 200
- Registration Number
- NCT06099626
- Locations
- 🇨🇳
Dazhi Zhang, Chongqing, Chongqing, China
The Safety and Tolerability of MY-586 COVID-19 Neutralizing Antibody Nasal Spray in Healthy Subjects
Not Applicable
Recruiting
- Conditions
- SARS-CoV-2Prevention
- Interventions
- Biological: MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2023-08-04
- Target Recruit Count
- 72
- Registration Number
- NCT05977101
- Locations
- 🇨🇳
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
Not yet recruiting
- Conditions
- Autoimmune DiseasesChronic Liver DiseaseHealthyMalignant Tumor
- Interventions
- Other: underling disease
- First Posted Date
- 2023-07-28
- Last Posted Date
- 2023-08-03
- Target Recruit Count
- 480
- Registration Number
- NCT05965843
Analysis of Factors Influencing the Efficacy of Levamlodipine Benzoate and Its Population Pharmacodynamic Modeling
Recruiting
- Conditions
- Hypertensive PatientsMonotherapy
- First Posted Date
- 2023-07-24
- Last Posted Date
- 2023-09-14
- Target Recruit Count
- 150
- Registration Number
- NCT05958524
- Locations
- 🇨🇳
Yu Xian, Chongqing, China
Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients
Recruiting
- Conditions
- Kidney TransplantationImmunosuppressive Agents
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2023-09-13
- Target Recruit Count
- 120
- Registration Number
- NCT05872815
- Locations
- 🇨🇳
The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
Phase 4
Not yet recruiting
- Conditions
- Anti-PD-1 AntibodyPeg-IFNαChronic Hepatitis b
- Interventions
- Drug: Anti-PD-1 antibodyDrug: NAsDrug: Peg-IFNα
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2023-04-27
- Target Recruit Count
- 120
- Registration Number
- NCT05771402
- Locations
- 🇨🇳
The 2nd affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
Phase 4
Not yet recruiting
- Conditions
- Anti-PD-1 AntibodyChronic Hepatitis b
- Interventions
- Drug: Anti-PD-1 antibodyDrug: NAs
- First Posted Date
- 2023-03-15
- Last Posted Date
- 2023-04-27
- Target Recruit Count
- 120
- Registration Number
- NCT05769816
- Locations
- 🇨🇳
The 2nd affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China
© Copyright 2025. All Rights Reserved by MedPath